Pioglitazone |
|
|
|
|
|
decrease |
Positive |
|
22 |
Chlorpromazine |
|
|
rat |
isolated liver mitochondria |
|
decrease |
Positive |
|
23 |
Haloperidol |
|
|
rat |
isolated liver mitochondria |
|
decrease |
Positive |
|
23 |
Risperidone |
|
|
rat |
isolated liver mitochondria |
|
decrease |
Positive |
|
23 |
quetiapine |
|
|
rat |
isolated liver mitochondria |
|
decrease |
Positive |
|
23 |
Antimycin A |
|
|
|
|
|
decrease |
Positive |
|
26 |
Myxothiazol |
|
|
bovine |
heart mitochondria |
|
decrease |
Positive |
|
29 |
Papaverine |
|
|
|
|
|
decrease |
Positive |
|
30 |
Thenoyltrifluoroacetone |
|
|
|
|
|
decrease |
Positive |
|
33 |
Acetaminophen |
|
|
|
|
|
decrease |
Positive |
|
35 |
Acetaminophen |
|
|
|
|
|
decrease |
Positive |
|
35 |
Acetylsalicylic acid |
|
|
|
|
|
decrease |
Positive |
|
35 |
Acetylsalicylic acid |
|
|
|
|
|
decrease |
Positive |
|
35 |
Flutamide |
|
|
|
|
|
decrease |
Positive |
|
35 |
Ketoconazole |
|
|
|
|
|
decrease |
Positive |
|
35 |
mefloquine |
|
|
|
|
|
decrease |
Positive |
|
35 |
Metformin |
|
|
|
|
|
decrease |
Positive |
|
35 |
Nefazodone |
|
|
|
|
|
decrease |
Positive |
|
35 |
Nitrofurantoin |
|
|
|
|
|
decrease |
Positive |
|
35 |
Paraquat |
|
|
|
|
|
decrease |
Positive |
|
35 |
paroxetine |
|
|
|
|
|
decrease |
Positive |
|
35 |
paroxetine |
|
|
|
|
|
decrease |
Positive |
|
35 |
paroxetine |
|
|
|
|
|
decrease |
Positive |
|
35 |
paroxetine |
|
|
|
|
|
decrease |
Positive |
|
35 |
Phenformin |
|
|
|
|
|
decrease |
Positive |
|
35 |
Pioglitazone |
|
|
|
|
|
decrease |
Positive |
|
35 |
Pioglitazone |
|
|
|
|
|
decrease |
Positive |
|
35 |
promethazine |
|
|
|
|
|
decrease |
Positive |
|
35 |
Rosiglitazone |
|
|
|
|
|
decrease |
Positive |
|
35 |
Rotenone |
|
|
|
|
|
decrease |
Positive |
|
35 |
Tamoxifen |
|
|
|
|
|
decrease |
Positive |
|
35 |
Tamoxifen |
|
|
|
|
|
decrease |
Positive |
|
35 |
Tamoxifen |
|
|
|
|
|
decrease |
Positive |
|
35 |
Tamoxifen |
|
|
|
|
|
decrease |
Positive |
|
35 |
Troglitazone |
|
|
|
|
|
decrease |
Positive |
|
35 |
Antimycin A |
|
|
|
|
|
decrease |
Positive |
|
35 |
Myxothiazol |
|
|
|
|
|
decrease |
Positive |
|
35 |
Oligomycin |
|
|
|
|
|
decrease |
Positive |
|
35 |
Thenoyltrifluoroacetone |
|
|
|
|
|
decrease |
Positive |
|
35 |
alpidem |
|
|
|
|
|
decrease |
Positive |
|
36 |
Amiodarone |
|
|
|
|
|
decrease |
Positive |
|
36 |
benzbromarone |
|
|
|
|
|
decrease |
Positive |
|
37 |
Chlorpromazine |
|
|
|
|
|
decrease |
Positive |
|
7 |
clomipramine |
|
|
|
|
|
decrease |
Positive |
|
38 |
Diclofenac |
|
|
|
|
|
decrease |
Positive |
|
39 |
Flutamide |
|
|
|
|
|
decrease |
Positive |
|
41 |
Ketoconazole |
|
|
|
|
|
decrease |
Positive |
|
36 |
lovastatin |
|
|
|
|
|
decrease |
Positive |
|
36 |
Phenformin |
|
|
|
|
|
decrease |
Positive |
|
43 |
Rosiglitazone |
|
|
|
|
|
decrease |
Positive |
|
7 |
Simvastatin |
|
|
|
|
|
decrease |
Positive |
|
7 |
sitaxsentan |
|
|
|
|
|
decrease |
Positive |
|
44 |
Tamoxifen |
|
|
|
|
|
decrease |
Positive |
|
46 |
Troglitazone |
|
|
|
|
|
decrease |
Positive |
|
7 |
Doxorubicin |
|
|
|
|
|
decrease |
Positive |
|
36 |
imipramine |
|
|
|
|
|
decrease |
Positive |
|
36 |
sertraline |
|
|
|
|
|
decrease |
Positive |
|
48 |
zoniporide |
|
|
|
|
|
decrease |
Positive |
|
50 |
pentamidine |
|
|
|
|
|
decrease |
Positive |
|
51 |
ritonavir |
|
|
|
|
|
decrease |
Positive |
|
36 |
Tenofovir |
|
|
|
|
|
decrease |
Positive |
|
52 |
Polymyxin B |
|
|
rat |
isolated liver mitochondria |
measurements of mitochondrial respiration; RST inhibition assay, RST uncoupling assay; IC 50ratio of glucose/galactose assay |
decrease |
Positive |
|
53 |
beclomethasone |
|
|
rat |
isolated liver mitochondria |
measurements of mitochondrial respiration; RST inhibition assay, RST uncoupling assay; IC 50ratio of glucose/galactose assay |
decrease |
Positive |
|
53 |
bicalutamide |
|
|
rat |
isolated liver mitochondria |
measurements of mitochondrial respiration; RST inhibition assay, RST uncoupling assay; IC 50ratio of glucose/galactose assay |
decrease |
Positive |
|
53 |
danazol |
|
|
rat |
isolated liver mitochondria |
measurements of mitochondrial respiration; RST inhibition assay, RST uncoupling assay; IC 50ratio of glucose/galactose assay |
decrease |
Positive |
|
53 |
ethynodiol diacetate |
|
|
rat |
isolated liver mitochondria |
measurements of mitochondrial respiration; RST inhibition assay, RST uncoupling assay; IC 50ratio of glucose/galactose assay |
decrease |
Positive |
|
53 |
retinoic acid |
|
|
rat |
isolated liver mitochondria |
measurements of mitochondrial respiration; RST inhibition assay, RST uncoupling assay; IC 50ratio of glucose/galactose assay |
decrease |
Positive |
|
53 |
aripiprazole |
|
|
rat |
isolated liver mitochondria |
measurements of mitochondrial respiration; RST inhibition assay, RST uncoupling assay; IC 50ratio of glucose/galactose assay |
decrease |
Positive |
|
53 |
axitinib |
|
|
rat |
isolated liver mitochondria |
measurements of mitochondrial respiration; RST inhibition assay, RST uncoupling assay; IC 50ratio of glucose/galactose assay |
decrease |
Positive |
|
53 |
clofilium |
|
|
rat |
isolated liver mitochondria |
measurements of mitochondrial respiration; RST inhibition assay, RST uncoupling assay; IC 50ratio of glucose/galactose assay |
decrease |
Positive |
|
53 |
tenidap |
|
|
rat |
isolated liver mitochondria |
measurements of mitochondrial respiration; RST inhibition assay, RST uncoupling assay; IC 50ratio of glucose/galactose assay |
decrease |
Positive |
|
53 |
darifenacin |
|
|
rat |
isolated liver mitochondria |
measurements of mitochondrial respiration; RST inhibition assay, RST uncoupling assay; IC 50ratio of glucose/galactose assay |
decrease |
Positive |
|
53 |
pimozide |
|
|
rat |
isolated liver mitochondria |
measurements of mitochondrial respiration; RST inhibition assay, RST uncoupling assay; IC 50ratio of glucose/galactose assay |
decrease |
Positive |
|
53 |
Gemfibrozil |
|
|
|
isolated mitochondria |
|
decrease |
Positive |
|
7 |
Amitriptyline |
|
|
pig |
brain mitochondria |
|
decrease |
Positive |
|
60 |
citalopram |
|
|
pig |
brain mitochondria |
|
decrease |
Positive |
|
62 |
citalopram |
|
|
pig |
brain mitochondria |
|
decrease |
Positive |
|
62 |
citalopram |
|
|
pig |
brain mitochondria |
|
decrease |
Positive |
|
62 |
Haloperidol |
|
|
|
|
|
decrease |
Positive |
|
23 |
propranolol |
|
|
pig |
brain mitochondria |
|
decrease |
Positive |
|
60 |
Indomethacin |
|
|
rat |
isolated liver mitochondria |
|
decrease |
Positive |
|
65 |
ochratoxin a |
|
|
rat |
isolated liver mitochondria |
|
decrease |
Positive |
|
66 |
tacrolimus |
|
|
rat |
isolated kidney mitochondria |
|
decrease |
Positive |
|
68 |
Piericidin A |
|
|
|
|
|
affect |
Positive |
|
53 |
rolliniastatin-2 |
|
|
|
|
|
affect |
Positive |
|
53 |
Idebenone |
|
|
|
|
|
affect |
Positive |
|
53 |
Rotenone |
|
|
|
|
|
affect |
Positive |
|
53 |
piericidin a |
|
|
|
|
|
affect |
Positive |
|
53 |
piericidin b |
|
|
|
|
|
affect |
Positive |
|
53 |
aureothin |
|
|
|
|
|
affect |
Positive |
|
53 |
amytal |
|
|
|
|
|
affect |
Positive |
|
53 |
4-alkyl-acridones |
|
|
|
|
|
affect |
Positive |
|
53 |
4′-alkyl-mpp+ analoguesc |
|
|
|
|
|
affect |
Positive |
|
53 |
phenoxan |
|
|
|
|
|
affect |
Positive |
|
53 |
quinol products |
|
|
|
|
|
affect |
Positive |
|
53 |
reduced q-2b |
|
|
|
|
|
affect |
Positive |
|
53 |
Myxothiazol |
|
|
|
|
|
affect |
Positive |
|
53 |
stigmatellin |
|
|
|
|
|
affect |
Positive |
|
53 |
TDS |
|
|
|
|
|
affect |
Positive |
|
53 |
2M-TIO |
|
|
|
|
|
affect |
Positive |
|
53 |
meperidine |
|
|
|
|
|
affect |
Positive |
|
53 |
para-nonylphenol |
|
|
|
|
|
affect |
Positive |
|
53 |
Diphenyleneiodonium chloride |
|
|
|
|
|
affect |
Positive |
|
69 |
ethoxyformic anhydride |
|
|
|
|
|
affect |
Positive |
|
70 |
ethoxyformic anhydride |
|
|
|
|
|
decrease |
Positive |
|
70 |
ethoxyformic anhydride |
|
|
|
|
|
decrease |
Positive |
|
70 |
flutolanil |
|
|
|
|
|
affect |
Positive |
|
71 |
atpenin a5 |
|
|
|
|
|
affect |
Positive |
|
71 |
Carboxin |
|
|
|
|
|
affect |
Positive |
|
71 |
penthiopyrad |
|
|
|
|
|
affect |
Positive |
|
71 |
boscalid |
|
|
|
|
|
affect |
Positive |
|
71 |
fluopyram |
|
|
|
|
|
affect |
Positive |
|
71 |
dinitrophenol-17 |
|
|
|
|
|
affect |
Positive |
|
71 |
atpenin a5 |
|
|
|
|
|
affect |
Positive |
|
72 |
thiophene carboxamides |
|
|
|
|
|
affect |
Positive |
|
73 |
HQNO |
|
|
|
|
|
affect |
Positive |
|
74 |
Polymyxin B |
1.6 μg/ml |
|
Mycobacterium smegmatis |
membrane-bound dehydrogenases |
|
decrease |
Positive |
IC50 |
76 |
nanaomycin a |
31 μg/ml |
|
Mycobacterium smegmatis |
membrane-bound dehydrogenases |
|
decrease |
Positive |
IC50 |
76 |
siccanin |
|
|
P. aeruginosa |
PAO1 cells |
|
affect |
Positive |
|
76 |
cyenopyrafen |
|
|
|
|
|
affect |
Positive |
|
77 |
pyflubumide |
|
|
|
|
|
affect |
Positive |
|
77 |
3-Nitropropionate |
|
|
|
|
|
affect |
Positive |
|
78 |
Malonate |
|
|
|
|
|
affect |
Positive |
|
79 |
british anti-lewisite |
|
|
|
|
|
affect |
Positive |
|
80 |
Myxothiazol |
|
|
|
|
|
affect |
Positive |
|
81 |
moas |
|
|
|
|
|
affect |
Positive |
|
82 |
azoxystrobin |
|
|
|
|
|
affect |
Positive |
|
83 |
oudemansin a |
|
|
|
|
|
affect |
Positive |
|
84 |
strobilurin a |
|
|
|
|
|
affect |
Positive |
|
84 |
cpmb-oxime |
|
|
|
|
|
affect |
Positive |
|
84 |
azoxystrobin |
100 mM |
incubated overnight |
bovine |
isolated heart mitochondria |
Measurements of redox potentials of the ISP |
affect |
Positive |
|
83 |
famoxadone |
100 mM |
incubated overnight |
bovine |
isolated heart mitochondria |
Measurements of redox potentials of the ISP |
affect |
Positive |
|
83 |
stigmatellin |
100 mM |
incubated overnight |
bovine |
isolated heart mitochondria |
Measurements of redox potentials of the ISP |
affect |
Positive |
|
83 |
uhdbt |
100 mM |
incubated overnight |
bovine |
isolated heart mitochondria |
Measurements of redox potentials of the ISP |
affect |
Positive |
|
83 |
hhdbt uhnq |
100 mM |
incubated overnight |
bovine |
isolated heart mitochondria |
Measurements of redox potentials of the ISP |
affect |
Positive |
|
83 |
dibromothymoquinone |
100 mM |
incubated overnight |
bovine |
isolated heart mitochondria |
Measurements of redox potentials of the ISP |
affect |
Positive |
|
83 |
Antimycin A |
|
|
bovine |
isolated heart mitochondria cytochrome bc1 complex |
|
affect |
Positive |
|
166 |
diuron |
|
|
|
|
|
affect |
Positive |
|
83 |
NQNO |
|
|
bovine |
isolated heart mitochondria cytochrome bc1 complex |
|
affect |
Positive |
|
166 |
NQNO |
|
|
bovine |
isolated heart mitochondria cytochrome bc1 complex |
|
affect |
Positive |
|
166 |
Carbon Monoxide |
|
|
|
|
|
affect |
Positive |
|
167 |
nitric oxide |
|
|
|
|
|
affect |
Positive |
|
167 |
Cyanide |
|
|
|
|
|
affect |
Positive |
|
167 |
azides |
|
|
|
|
|
affect |
Positive |
|
167 |
sulfide |
|
|
|
|
|
affect |
Positive |
|
167 |
formate |
|
|
|
|
|
affect |
Positive |
|
167 |
ethylxanthate |
|
|
|
|
|
affect |
Positive |
|
167 |
bisulfate |
|
|
|
|
|
affect |
Positive |
|
167 |
semicarbazide |
|
|
|
|
|
affect |
Positive |
|
167 |
salicyaldoxime |
|
|
|
|
|
affect |
Positive |
|
167 |
ethylxanthate |
|
|
|
|
|
decrease |
Positive |
|
167 |
bisulfate |
|
|
|
|
|
decrease |
Positive |
|
167 |
semicarbazide |
|
|
|
|
|
decrease |
Positive |
|
167 |
salicyaldoxime |
|
|
|
|
|
decrease |
Positive |
|
167 |
adda 5 |
|
|
human |
U251 mitochondria |
CcO activity assay |
affect |
Positive |
|
168 |
tetrathiomolybdate |
30 μM |
48 hour |
human |
ECC-1 |
|
affect |
Positive |
|
169 |
tetrathiomolybdate |
30 μM |
48 hour |
human |
IGROV-1 |
|
affect |
Positive |
|
169 |
Oligomycin |
152 μg inhibitor/mg protein |
|
E. coli |
membrane vesicle, pH gradient formation |
|
affect |
Positive |
|
170 |
Oligomycin |
7.1 μg inhibitor/mg protein |
|
C. asciculate |
SMP-ATPase |
|
affect |
Positive |
IC50 |
170 |
Oligomycin |
2.0-3.0 μg inhibitor/mg protein |
|
S. cerevisiae |
SMP-ATPase |
|
affect |
Positive |
IC50 |
170 |
Oligomycin |
0.3 μM |
|
human NCI-60 cell lines |
F0F1-ATPase |
|
affect |
Positive |
IC50 |
170 |
Oligomycin |
15 ng inhibitor/mg protein |
|
N. crassa |
SMP-ATPase |
|
affect |
Positive |
Ki |
170 |
Oligomycin |
0.21 μM |
|
bovine |
heart MF0F1-ATPase |
|
affect |
Positive |
Ki |
170 |
Oligomycin |
0.4 μg inhibitor/mg protein |
|
bovine |
heart SMP-ATPase |
|
affect |
Positive |
95% inhibition |
170 |
Oligomycin |
0.5 μg/ml |
|
rat |
liver SMP-ATPase |
|
affect |
Positive |
75% inhibition |
170 |
ossamycin |
46 μg of inhibitor/mg protein |
|
E. coli |
pH gradient formation by membrane vesicle |
|
affect |
Positive |
IC50 |
170 |
ossamycin |
8 μM |
|
human NCI-60 cell lines |
F0F1-ATPase |
|
affect |
Positive |
IC50 |
170 |
ossamycin |
1.3 μg of inhibitor/mg protein |
|
S. cerevisiae |
SMP-ATPase |
|
affect |
Positive |
IC50 |
170 |
venturicidin B |
|
|
|
|
|
affect |
Positive |
|
170 |
Bedaquiline |
|
|
|
|
|
affect |
Positive |
|
170 |
tributyltin chloride |
200 nM |
|
E. coli and |
F0F1-ATPase |
|
affect |
Positive |
|
170 |
tributyltin chloride |
200 nM |
|
I. tartaricus |
F0F1-ATPase |
|
affect |
Positive |
|
170 |
tributyltin chloride |
1 μM |
|
C. thermoaceticum |
membrane-bound F0F1-ATPase |
|
affect |
Positive |
47% inhibition |
170 |
tributyltin chloride |
5 μM |
|
C. thermoaceticum |
membrane-bound F0F1-ATPase |
|
affect |
Positive |
87% inhibition |
170 |
tributyltin chloride |
1 μM |
|
|
TF0F1-ATPase |
|
affect |
Positive |
80% inhibition |
170 |
NCCD |
0.65 nmol/mg protein |
|
bovine |
heart SMP-ATPase |
|
affect |
Positive |
IC50 |
170 |
NCCD |
1 nmol NCCD/mg protein |
|
bovine |
heart SMP-ATPase |
|
affect |
Positive |
85% inhibition |
170 |
substrate analogs |
|
|
|
|
|
affect |
Positive |
|
170 |
tentoxin |
∼0.6 mol/mol |
|
spinach |
CF1-ATPase |
|
affect |
Positive |
IC50 |
170 |
tentoxin |
50 nM |
|
spinach |
CF1(-ɛ)-ATPase |
|
affect |
Positive |
IC50 |
170 |
tentoxin |
0.4-0.6 μM |
|
lettuce |
chloroplasts, photophosphorylation |
|
affect |
Positive |
IC50 |
170 |
tentoxin |
10 nM |
|
spinach |
CF1(-ɛ)-ATPase |
|
affect |
Positive |
Ki |
170 |
tentoxin |
30-60 μM |
|
|
TF1-ATPase |
|
affect |
Positive |
Ki |
170 |
tentoxin |
8-10 nM |
|
spinach |
CF1(-ɛ)-ATPase |
|
affect |
Positive |
Kd |
170 |
efrapeptins |
|
|
|
|
|
affect |
Positive |
|
170 |
azide |
|
|
|
|
|
affect |
Positive |
|
170 |
resveratrol |
|
|
|
|
|
affect |
Positive |
|
170 |
N,N'-dicyclohexylcarbodiimide |
0.2 μg of inhibitor/mg protein |
|
S. cerevisiae |
SMP-ATPase |
|
affect |
Positive |
IC50 |
170 |
N,N'-dicyclohexylcarbodiimide |
1-5 μg of inhibitor/mg protein |
|
T. pyriformis |
SMP-ATPase |
|
affect |
Positive |
IC50 |
170 |
N,N'-dicyclohexylcarbodiimide |
200 μMa in less than 5 min and at ∼40 μMa in 30 min |
|
R. rubrum |
F1-ATPase |
|
affect |
Positive |
|
170 |
N,N'-dicyclohexylcarbodiimide |
1.9 μg/mg protein |
|
C. fasciculata |
SMP-ATPase |
|
affect |
Positive |
IC50 |
170 |
N,N'-dicyclohexylcarbodiimide |
1 mol DCCD/mol F1 |
|
|
EF1-ATPase |
|
affect |
Positive |
95% inhibition |
170 |
N,N'-dicyclohexylcarbodiimide |
30 μM |
|
|
membrane-bound EF0F1-ATPase |
|
affect |
Positive |
maximal 70-80% inhibition |
170 |
N,N'-dicyclohexylcarbodiimide |
5 μM |
|
C. thermoaceticum |
membrane-bound F0F1-ATPase |
|
affect |
Positive |
47% inhibition |
170 |
N,N'-dicyclohexylcarbodiimide |
2 mol inhibitor bound/mol F1 |
|
bovine |
heart MF1-ATPase |
|
affect |
Positive |
97% inhibition |
170 |
N,N'-dicyclohexylcarbodiimide |
1 mol inhibitor/mol F0 |
|
bovine |
heart SMP-ATPase |
|
affect |
Positive |
maximal inhibition |
170 |
N,N'-dicyclohexylcarbodiimide |
2 mol inhibitor/mol F0 |
|
bovine |
heart H+-translocation |
|
affect |
Positive |
maximal inhibition |
170 |
N,N'-dicyclohexylcarbodiimide |
1 mol inhibitor/mol F0 |
|
E. coli |
membrane H+-translocation |
|
affect |
Positive |
maximal inhibition |
170 |
N,N'-dicyclohexylcarbodiimide |
|
|
|
|
|
affect |
Positive |
|
170 |
woodward's reagent k |
|
|
|
|
|
affect |
Positive |
|
170 |
woodward's reagent k |
|
|
|
|
|
affect |
Positive |
|
170 |
cyclophilin D |
|
|
|
|
|
affect |
Positive |
|
171 |
Rotenone |
0.07 nmol/mg |
|
bovine |
mitochondria |
NADH–Q |
decrease |
Positive |
IC50 |
94 |
Rotenone |
0.04 nmol/mg |
|
bovine |
mitochondria |
NADH–O2 |
decrease |
Positive |
IC50 |
94 |
Deguelin |
4.2 nmol/mg |
|
bovine |
mitochondria |
NADH–Q |
decrease |
Positive |
IC50 |
95 |
Piericidin A |
0.06 nmol/mg |
|
bovine |
mitochondria |
NADH–Q |
decrease |
Positive |
IC50 |
94 |
Piericidin A |
0.03 nmol/mg |
|
bovine |
mitochondria |
NADH:O2 |
decrease |
Positive |
IC50 |
94 |
Ubicidin-3 |
0.17 nmol/mg |
|
bovine |
mitochondria |
NADH:O2 |
decrease |
Positive |
IC50 |
96 |
Rolliniastatin-1 |
0.03 nmol/mg |
|
bovine |
mitochondria |
NADH–Q |
decrease |
Positive |
IC50 |
98 |
rolliniastatin-2 |
0.06 nmol/mg |
|
bovine |
mitochondria |
NADH–Q-1 |
decrease |
Positive |
IC50 |
98 |
Otivarin |
0.2 nmol/mg |
|
bovine |
mitochondria |
NADH–Q |
decrease |
Positive |
IC50 |
98 |
phenoxan |
0.04 nmol/mg |
|
bovine |
mitochondria |
NADH–Q |
decrease |
Positive |
IC50 |
94 |
Thiangazole |
0.04 nmol/mg |
|
bovine |
mitochondria |
NADH–Q |
decrease |
Positive |
IC50 |
94 |
myxalamid pi |
15 nmol/mg |
|
bovine |
mitochondria |
NADH–Q |
decrease |
Positive |
IC50 |
94 |
phenalamid a2 |
0.6 nmol/mg |
|
bovine |
mitochondria |
NADH–Q |
decrease |
Positive |
IC50 |
94 |
Aurachin a |
8.0 nmol/mg |
|
bovine |
mitochondria |
NADH–Q |
decrease |
Positive |
IC50 |
94 |
Myxothiazol |
20 nmol/mg |
|
bovine |
mitochondria |
NADH–Q |
decrease |
Positive |
IC50 |
99 |
stigmatellin |
100 nmol/mg |
|
bovine |
mitochondria |
NADH–Q |
decrease |
Positive |
IC50 |
99 |
TDS |
40 nmol/mg |
|
bovine |
mitochondria |
NADH–Q |
decrease |
Positive |
IC50 |
99 |
aureothin |
0.3 nmol/mg |
|
bovine |
mitochondria |
NADH–Q |
decrease |
Positive |
IC50 |
94 |
Cochlioquinone b |
83 nmol/mg |
|
bovine |
mitochondria |
NADH:O2 |
decrease |
Positive |
IC50 |
100 |
strobilurin a |
>100 nmol/mg |
|
bovine |
mitochondria |
NADH–Q |
decrease |
Positive |
IC50 |
99 |
pterulone |
36 μM |
|
bovine |
mitochondria |
NADH:O2 |
decrease |
Positive |
IC50 |
101 |
Capsaicin |
20–30 μM |
|
bovine |
mitochondria |
NADH–Q |
decrease |
Positive |
IC50 |
102 |
Capsaicin |
20–30 μM |
|
bovine |
mitochondria |
NADH:O2 |
decrease |
Positive |
IC50 |
102 |
Rhein |
30 μM |
|
bovine |
mitochondria |
NADH:O2 |
decrease |
Positive |
IC50 |
104 |
Papaverine |
5 μM |
|
bovine |
mitochondria |
NADH–Q-1 |
decrease |
Positive |
IC50 |
30 |
Ubiquinone-2 |
2 μM |
|
bovine |
mitochondria |
NADH–Q-1 |
decrease |
Positive |
IC50 |
106 |
Ubiquinone-3 |
40 μM |
|
bovine |
mitochondria |
NADH–Q |
decrease |
Positive |
IC50 |
107 |
Idebenone |
0.4 μM |
|
|
|
NADH–Q |
decrease |
Positive |
IC50 |
106 |
Pyridaben |
2.4 nM |
|
|
|
NADH–Q-1 |
decrease |
Positive |
IC50 |
108 |
Fenpyroximate |
4.6 nM |
|
|
|
NADH–Q-1 |
decrease |
Positive |
IC50 |
108 |
Fenpyroximate |
18 nM |
|
|
|
NADH–Q |
decrease |
Positive |
IC50 |
103 |
Tebufenpyrad |
6 nM |
|
|
|
NADH–Q-1 |
decrease |
Positive |
IC50 |
108 |
fenazaquin |
20 nM |
|
|
|
NADH–Q-1 |
decrease |
Positive |
IC50 |
109 |
Benzimidazole |
3 nM |
|
|
|
NADH–Q |
decrease |
Positive |
IC50 |
94 |
cyhalothrin |
0.6 μM |
|
|
|
NADH–DQ |
decrease |
Positive |
IC50 |
110 |
6-chloro-benzothiadiazole |
0.1 mM |
|
|
|
NADH:O2 |
decrease |
Positive |
IC50 |
111 |
2M-TIO |
40 μM |
|
|
|
NADH–Q-1 |
decrease |
Positive |
IC50 |
112 |
amytal |
0.2 mM |
|
|
|
NADH–Q-1 |
decrease |
Positive |
IC50 |
112 |
meperidine |
0.1 mM |
|
|
|
NADH–Q-1 |
decrease |
Positive |
IC50 |
108 |
MPP+ |
0.3 mM |
|
|
|
NADH:O2 |
decrease |
Positive |
IC50 |
114 |
MPP+ |
2–4 mM |
|
|
|
NADH–Q |
decrease |
Positive |
IC50 |
115 |
4'-decyl-mpp+ |
1.7 μM |
|
|
|
NADH:O2 |
decrease |
Positive |
IC50 |
115 |
MQ18 |
0.2 μM |
|
|
|
NADH–Q-1 |
decrease |
Positive |
IC50 |
116 |
2-methylharmine |
0.18 mM |
|
|
|
NADH:O2 |
decrease |
Positive |
IC50 |
117 |
TIQ |
2 mM |
|
|
|
NADH:O2 |
decrease |
Positive |
IC50 |
118 |
Haloperidol |
3 μM |
|
|
|
NADH–Q-1 |
decrease |
Positive |
IC50 |
119 |
HPP+ |
15 μM |
|
|
|
NADH–Q-1 |
decrease |
Positive |
IC50 |
119 |
Dequalinium Chloride |
11 μM |
|
|
|
NADH:O2 |
decrease |
Positive |
IC50 |
120 |
Cinnarizine |
5–10 μM |
|
|
|
NADH–Q-1 |
decrease |
Positive |
IC50 |
121 |
para-nonylphenol |
20 μM |
|
|
|
NADH–Q |
decrease |
Positive |
IC50 |
108 |
Catechol |
0.4 mM |
|
|
|
NADH–Q |
decrease |
Positive |
IC50 |
108 |
CCCP |
85 μM |
|
|
|
NADH–Q-1 |
decrease |
Positive |
IC50 |
108 |
Erythrosin 5'-iodoacetamide |
20 nM |
|
|
|
NADH–O2 |
decrease |
Positive |
IC50 |
126 |
Safranine |
17 μM |
|
|
|
NADH–Q |
decrease |
Positive |
IC50 |
127 |
dioc5(3) |
1.5 μM |
|
|
|
NADH–Q |
decrease |
Positive |
IC50 |
127 |
dioc6(3) |
80 nM |
|
|
|
NADH–O2 |
decrease |
Positive |
IC50 |
126 |
Diphenyleneiodonium chloride |
0.23 μM |
|
|
|
NADH–Q-1c |
decrease |
Positive |
IC50 |
128 |
N,N'-dicyclohexylcarbodiimide |
0.1 mM |
|
|
|
NADH–Q-1 |
decrease |
Positive |
IC50 |
129 |
o-phenanthroline |
0.25 mM |
|
|
|
NADH–Q |
decrease |
Positive |
IC50 |
130 |
Leucinostatin |
11 μg/mg protein |
|
C. asciculate |
SMP-ATPase |
|
decrease |
Positive |
IC50 |
131 |
Leucinostatin |
2 μg inhibitor/ml |
|
spinach |
chloroplast |
|
decrease |
Positive |
IC50 |
132 |
Leucinostatin |
0.1-0.4 μg/mg protein |
|
rat |
isolated liver mitochondria |
|
decrease |
Positive |
|
133 |
efrapeptins |
0.56 mol/mol F1 |
|
bovine |
heart MF1-ATPase |
|
decrease |
Positive |
IC50 |
134 |
efrapeptins |
70 ng/ml |
|
C. asciculate |
MF1-ATPase |
|
decrease |
Positive |
IC50 |
135 |
efrapeptins |
0.3 μM |
|
human |
umbilical vein endothelial cell, nonmitochondrial ATP synthase |
|
decrease |
Positive |
IC50 |
136 |
efrapeptins |
0.5 μg/ml |
|
R. rubrum |
chromatophores |
|
decrease |
Positive |
IC50 |
137 |
efrapeptins |
0.05-0.5 μg of inhibitor/mg protein |
|
T. pyriformis |
SMP-ATPase |
|
decrease |
Positive |
IC50 |
138 |
efrapeptins |
21.5 μM |
|
|
EF1-ATPase |
|
decrease |
Positive |
ki |
139 |
efrapeptins |
10 nM |
|
bovine |
heart MF1-ATPase |
|
decrease |
Positive |
kd |
134 |
efrapeptins |
2.4 mol inhibitor/mol enzyme |
|
bovine |
heart SMP-ATPase |
|
decrease |
Positive |
complete inhibition |
134 |
resveratrol |
27.7 μM |
|
rat |
brain SMP, ATP synthesis |
|
decrease |
Positive |
|
140 |
resveratrol |
14 μM |
|
rat |
liver MF1-ATPase |
|
decrease |
Positive |
|
141 |
resveratrol |
19 μM |
|
rat |
brain M F0F1-ATPase |
|
decrease |
Positive |
|
140 |
resveratrol |
6.4 μM |
|
bovine |
bovine heart MF1-ATPase |
|
decrease |
Positive |
|
142 |
resveratrol |
2 μM |
|
human |
human umbilical vein endothelial cell, nonmitochondrial ATP synthase, ATP synthesis |
|
decrease |
Positive |
|
136 |
Diethylstilbestrol |
10 μM |
|
rat |
liver MF0F1-ATPase |
|
decrease |
Positive |
|
143 |
Diethylstilbestrol |
10-25 μM |
|
rat |
brain MF0F1-ATPase |
|
decrease |
Positive |
|
141 |
SITS |
∼1.3 μM |
|
V. parahaemolyticus |
F0F1-ATPase |
|
decrease |
Positive |
|
144 |
SITS |
25 μM |
|
V. parahaemolyticus |
F1-ATPase |
|
decrease |
Positive |
95% inhibition |
145 |
DIDS |
20.9 μM |
|
rat |
liver MF1ATPase |
|
decrease |
Positive |
|
146 |
quercetin |
5 kmol/mol |
|
bovine |
heart MF1-ATPase |
|
decrease |
Positive |
IC50 |
147 |
quercetin |
85 μM |
|
bovine |
heart MF1-ATPase |
|
decrease |
Positive |
IC50 |
148 |
quercetin |
180 μM |
|
bovine |
heart SMP-ATPase |
|
decrease |
Positive |
IC50 |
148 |
quercetin |
50 μM |
|
rat |
brain F0F1-ATPase |
|
decrease |
Positive |
IC50 |
140 |
quercetin |
3 μM |
|
rat |
liver F1-ATPase |
|
decrease |
Positive |
IC50 |
141 |
quercetin |
2 kmol/mola |
|
spinach |
CF1-ATPase |
|
decrease |
Positive |
|
147 |
quercetin |
2.6 μg/mg protein |
|
C. asciculate |
SMP-ATPase |
|
decrease |
Positive |
IC50 |
131 |
quercetin |
0.2 mM |
|
pig |
heart MF1-ATPase |
|
decrease |
Positive |
Ki |
149 |
quercetin |
27 μM |
|
bovine |
heart MF1-ATPase |
|
decrease |
Positive |
Kd |
147 |
quercetin |
5 μM |
|
C. thermoaceticum |
membrane-bound F0F1-ATPase |
|
decrease |
Positive |
46% inhibition |
150 |
kaempferol |
55 μM |
|
rat |
brain MF0F1-ATPase |
|
decrease |
Positive |
IC50 |
140 |
morin |
60 μM |
|
rat |
brain MF0F1-ATPase |
|
decrease |
Positive |
IC50 |
140 |
apigenin |
105 μM |
|
rat |
brain MF0F1-ATPase |
|
decrease |
Positive |
IC50 |
140 |
genistein |
55 μM |
|
rat |
brain MF0F1-ATPase |
|
decrease |
Positive |
IC50 |
140 |
genistein |
50 μM |
|
rat |
liver F1-ATPase |
|
decrease |
Positive |
10% inhibition |
141 |
Biochanin A |
65 μM |
|
rat |
brain MF0F1-ATPase |
|
decrease |
Positive |
IC50 |
140 |
Daidzein |
127 μM |
|
rat |
brain MF0F1-ATPase |
|
decrease |
Positive |
IC50 |
151 |
Oligomycin |
152 μg inhibitor/mg protein |
|
E. coli |
membrane vesicle |
|
decrease |
Positive |
IC50 |
152 |
Oligomycin |
7.1 μg inhibitor/mg protein |
|
C. asciculate |
SMP-ATPase |
|
decrease |
Positive |
IC50 |
131 |
Oligomycin |
2.0-3.0 μg inhibitor/mg protein |
|
S. cerevisiae |
SMP-ATPase |
|
decrease |
Positive |
IC50 |
153 |
Oligomycin |
0.3 μM |
|
human |
NCI-60 cell lines, F0F1-ATPase |
|
decrease |
Positive |
IC50 |
154 |
Oligomycin |
15 ng inhibitor/mg protein |
|
N. crassa |
SMP-ATPase |
|
decrease |
Positive |
Ki |
155 |
Oligomycin |
0.21 μM |
|
bovine |
heart MF0F1-ATPase |
|
decrease |
Positive |
Ki |
156 |
Oligomycin |
0.4 μg inhibitor/mg protein |
|
bovine |
heart SMP-ATPase |
|
decrease |
Positive |
95% inhibition |
157 |
Oligomycin |
0.5 μg/ml |
|
rat |
liver SMP-ATPase |
|
decrease |
Positive |
75% inhibition |
158 |
peliomycin |
4.5 μg inhibitor/mg protein |
|
S. cerevisiae |
SMP-ATPase |
|
decrease |
Positive |
IC50 |
153 |
venturicidin B |
9 μg inhibitor/mg protein |
|
E. coli |
membrane vesicle |
|
decrease |
Positive |
IC50 |
152 |
venturicidin B |
11 μg inhibitor/mg protein |
|
E. coli |
membrane-bound ATPase |
|
decrease |
Positive |
IC50 |
152 |
venturicidin B |
0.13 μg inhibitor/mg protein |
|
|
|
|
decrease |
Positive |
IC50 |
153 |
venturicidin B |
0.06-0.18 (A and B) and 11.0 (X) μg inhibitor/mg protein |
|
S. cerevisiae |
SMP-ATPase |
|
decrease |
Positive |
IC50 |
159 |
venturicidin B |
5-11 μg inhibitor/mg protein |
|
T. pyriformis |
|
|
decrease |
Positive |
IC50 |
138 |
venturicidin B |
3.0 μg/mg protein |
|
C. asciculate |
SMP-ATPase |
|
decrease |
Positive |
IC50 |
131 |
venturicidin B |
0.5 μM |
|
spinach |
thylakoids |
|
decrease |
Positive |
IC50 |
160 |
venturicidin B |
0.5 μM |
|
spinach |
thylakoids, ATPase |
|
decrease |
Positive |
IC50 |
160 |
ossamycin |
1.3 μg of inhibitor/mg protein |
|
S. cerevisiae |
SMP-ATPase |
|
decrease |
Positive |
IC50 |
153 |
ossamycin |
46 μg of inhibitor/mg protein |
|
E. coli |
membrane vesicle |
|
decrease |
Positive |
IC50 |
152 |
ossamycin |
8 μM |
|
human |
NCI-60 cell lines, F0F1-ATPase |
|
decrease |
Positive |
IC50 |
154 |
apoptolidin |
4-5 μM |
|
S. cerevisiae |
membrane-bound F0F1-ATPase |
|
decrease |
Positive |
Ki |
161 |
apoptolidin |
18 μM |
|
human |
NCI-60 cell lines, F0F1-ATPase |
|
decrease |
Positive |
IC50 |
154 |
cytovaricin |
1 μM |
|
human |
NCI-60 cell lines, F0F1-ATPase |
|
decrease |
Positive |
IC50 |
154 |
cytovaricin |
0.4 μM |
|
S. cerevisiae |
membrane-bound F0F1-ATPase |
|
decrease |
Positive |
Ki |
161 |
ossamycin |
0.8 μM |
|
|
60 human cancer cell lines of the National Cancer Institute |
|
decrease |
Positive |
mean |
184 |
Perhexiline |
|
|
|
|
|
affect |
Positive |
|
227 |
atpenin a5 |
|
|
bovine |
heart mitochondria |
|
affect |
Positive |
|
192 |
Carboxin |
|
|
bovine |
heart mitochondria |
|
affect |
Positive |
|
192 |
Thenoyltrifluoroacetone |
|
|
bovine |
heart mitochondria |
|
affect |
Positive |
|
192 |
HQNO |
|
|
bovine |
heart mitochondria |
|
affect |
Positive |
|
192 |
Chlorpromazine |
|
|
|
|
|
inhibit |
Positive |
|
197 |
Haloperidol |
|
|
|
|
|
inhibit |
Positive |
|
197 |
Clozapine |
|
|
|
|
|
inhibit |
Positive |
|
197 |
Nefazodone |
|
|
|
|
|
inhibit |
Positive |
|
197 |
Metformin |
|
|
|
|
|
inhibit |
Positive |
|
197 |
Phenformin |
|
|
|
|
|
inhibit |
Positive |
|
197 |
Troglitazone |
|
|
|
|
|
inhibit |
Positive |
|
197 |
Rosiglitazone |
|
|
|
|
|
inhibit |
Positive |
|
197 |
Pioglitazone |
|
|
|
|
|
inhibit |
Positive |
|
197 |
Oligomycin |
8 nM |
|
bovine |
heart mitochondria |
Measurement of complex V activity |
decrease |
Positive |
IC50 |
3 |
aurovertin B |
1.5 μM |
|
bovine |
heart mitochondria |
Measurement of complex V activity |
decrease |
Positive |
IC50 |
3 |
Amiodarone |
50 μM |
|
bovine |
heart mitochondria |
Measurement of complex I activity |
decrease |
Positive |
p < 0.05 |
3 |
Amiodarone |
50 μM |
|
bovine |
heart mitochondria |
Measurement of complex II + III activity |
decrease |
Positive |
p < 0.001 |
3 |
Amiodarone |
50 μM |
|
bovine |
heart mitochondria |
Measurement of complex II + III activity |
decrease |
Positive |
p < 0.001 |
3 |
Amiodarone |
50 μM |
|
bovine |
heart mitochondria |
Measurement of complex IV activity |
decrease |
Positive |
p < 0.05 |
3 |
Amiodarone |
50 μM |
|
bovine |
heart mitochondria |
Measurement of complex V activity |
decrease |
Positive |
p < 0.001 |
3 |
Chlorpromazine |
50 μM |
|
bovine |
heart mitochondria |
Measurement of complex II + III activity |
decrease |
Positive |
p < 0.001 |
3 |
Chlorpromazine |
50 μM |
|
bovine |
heart mitochondria |
Measurement of complex II + III activity |
decrease |
Positive |
p < 0.001 |
3 |
Chlorpromazine |
50 μM |
|
bovine |
heart mitochondria |
Measurement of complex V activity |
decrease |
Positive |
p < 0.001 |
3 |
Diclofenac |
50 μM |
|
bovine |
heart mitochondria |
Measurement of complex V activity |
decrease |
Positive |
p < 0.01 |
3 |
gefitinib |
50 μM |
|
bovine |
heart mitochondria |
Measurement of complex IV activity |
decrease |
Positive |
p < 0.05 |
3 |
gefitinib |
50 μM |
|
bovine |
heart mitochondria |
Measurement of complex V activity |
decrease |
Positive |
p < 0.001 |
3 |
Nefazodone |
50 μM |
|
bovine |
heart mitochondria |
Measurement of complex I activity |
decrease |
Positive |
p < 0.001 |
3 |
Nefazodone |
50 μM |
|
bovine |
heart mitochondria |
Measurement of complex II + III activity |
decrease |
Positive |
p < 0.01 |
3 |
Nefazodone |
50 μM |
|
bovine |
heart mitochondria |
Measurement of complex II + III activity |
decrease |
Positive |
p < 0.01 |
3 |
Nefazodone |
50 μM |
|
bovine |
heart mitochondria |
Measurement of complex IV activity |
decrease |
Positive |
p < 0.001 |
3 |
Nefazodone |
50 μM |
|
bovine |
heart mitochondria |
Measurement of complex V activity |
decrease |
Positive |
p < 0.001 |
3 |
paroxetine |
50 μM |
|
bovine |
heart mitochondria |
Measurement of complex I activity |
decrease |
Positive |
p < 0.01 |
3 |
paroxetine |
50 μM |
|
bovine |
heart mitochondria |
Measurement of complex II + III activity |
decrease |
Positive |
p < 0.001 |
3 |
paroxetine |
50 μM |
|
bovine |
heart mitochondria |
Measurement of complex II + III activity |
decrease |
Positive |
p < 0.001 |
3 |
paroxetine |
50 μM |
|
bovine |
heart mitochondria |
Measurement of complex V activity |
decrease |
Positive |
p < 0.001 |
3 |
Simvastatin |
50 μM |
|
bovine |
heart mitochondria |
Measurement of complex I activity |
decrease |
Positive |
p < 0.01 |
3 |
Simvastatin |
50 μM |
|
bovine |
heart mitochondria |
Measurement of complex II + III activity |
decrease |
Positive |
p < 0.001 |
3 |
Simvastatin |
50 μM |
|
bovine |
heart mitochondria |
Measurement of complex II + III activity |
decrease |
Positive |
p < 0.001 |
3 |
Simvastatin |
50 μM |
|
bovine |
heart mitochondria |
Measurement of complex IV activity |
decrease |
Positive |
p < 0.001 |
3 |
Simvastatin |
50 μM |
|
bovine |
heart mitochondria |
Measurement of complex V activity |
decrease |
Positive |
p < 0.001 |
3 |
Tamoxifen |
50 μM |
|
bovine |
heart mitochondria |
Measurement of complex II + III activity |
decrease |
Positive |
p < 0.001 |
3 |
Tamoxifen |
50 μM |
|
bovine |
heart mitochondria |
Measurement of complex II + III activity |
decrease |
Positive |
p < 0.001 |
3 |
Tamoxifen |
50 μM |
|
bovine |
heart mitochondria |
Measurement of complex IV activity |
decrease |
Positive |
p < 0.001 |
3 |
Tamoxifen |
50 μM |
|
bovine |
heart mitochondria |
Measurement of complex V activity |
decrease |
Positive |
p < 0.001 |
3 |
Tamoxifen |
15 μM |
|
bovine |
heart mitochondria |
Measurement of complex II + III activity |
decrease |
Positive |
IC50 |
3 |
Tamoxifen |
15 μM |
|
bovine |
heart mitochondria |
Measurement of complex II + III activity |
decrease |
Positive |
IC50 |
3 |
Tamoxifen |
26.6 μM |
|
bovine |
heart mitochondria |
Measurement of complex IV activity |
decrease |
Positive |
IC50 |
3 |
Tamoxifen |
8.1 μM |
|
bovine |
heart mitochondria |
Measurement of complex V activity |
decrease |
Positive |
IC50 |
3 |
Tamoxifen |
4 μM |
|
bovine |
heart mitochondria |
Measurement of complex I activity |
decrease |
Positive |
IC50 |
3 |
Tamoxifen |
1.6 μM |
|
bovine |
heart mitochondria |
Measurement of complex V activity |
decrease |
Positive |
IC50 |
3 |
Tamoxifen |
30 μM |
|
bovine |
heart mitochondria |
Measurement of complex II + III activity |
decrease |
Positive |
IC50 |
3 |
Tamoxifen |
30 μM |
|
bovine |
heart mitochondria |
Measurement of complex II + III activity |
decrease |
Positive |
IC50 |
3 |
Tamoxifen |
29 μM |
|
bovine |
heart mitochondria |
Measurement of complex V activity |
decrease |
Positive |
IC50 |
3 |
Tamoxifen |
26 μM |
|
bovine |
heart mitochondria |
Measurement of complex V activity |
decrease |
Positive |
IC50 |
3 |
Zidovudine |
|
|
|
|
|
Interfere |
Positive |
|
307 |
Acyclovir |
|
|
|
|
|
Interfere |
Positive |
|
307 |
Ganciclovir |
|
|
|
|
|
Interfere |
Positive |
|
307 |
Zalcitabine |
|
|
|
|
|
Interfere |
Positive |
|
307 |
tetracyclines |
|
|
|
|
|
decrease |
Positive |
|
307 |
Ciprofloxacin |
|
|
|
|
|
decrease |
Positive |
|
307 |
Clozapine |
|
|
|
|
|
decrease |
Positive |
|
307 |
sertraline |
|
|
rat |
brain mitochondria |
|
decrease |
Positive |
|
307 |
Fluoxetine |
|
|
rat |
brain mitochondria |
|
decrease |
Positive |
|
307 |
sertraline |
|
|
rat |
liver mitochondria |
|
decrease |
Positive |
|
307 |
Fluoxetine |
|
|
rat |
liver mitochondria |
|
decrease |
Positive |
|
307 |
atorvastatin |
|
|
|
C2C12 myoblasts |
|
affect |
Positive |
|
180 |
Cerivastatin |
100uM |
|
|
C2C12 myoblasts |
measured ubiquinol:cytochrome c oxidoreductase activity in broken C2C12 mitochondria after acute statin exposure at a fixed concentration for all compounds |
decrease |
Positive |
|
180 |
pitavastatin |
100uM |
|
|
C2C12 myoblasts |
measured ubiquinol:cytochrome c oxidoreductase activity in broken C2C12 mitochondria after acute statin exposure at a fixed concentration for all compounds |
decrease |
Positive |
|
180 |
lovastatin |
100uM |
|
|
C2C12 myoblasts |
measured ubiquinol:cytochrome c oxidoreductase activity in broken C2C12 mitochondria after acute statin exposure at a fixed concentration for all compounds |
decrease |
Positive |
|
180 |
Simvastatin |
100uM |
|
|
C2C12 myoblasts |
Measured ubiquinol:cytochrome c oxidoreductase activity in broken C2C12 mitochondria after acute statin exposure at a fixed concentration for all compounds. The lactone forms of the indicated statins were included in the assay medium at their cytotoxic EC50 concentration for measurement of their effect on the catalytic capacity. |
decrease |
Positive |
|
180 |
Simvastatin |
200uM |
|
bovine |
heart mitochondria |
Reduction of the CIII cytochromes c1 and b was determined spectrophotometrically in bovine heart mitochondria. |
affect |
Positive |
p < 0.01 |
180 |
Metformin |
5 mM |
24 hours |
human |
MCF7 |
Meassurement of mitochondrial respiration |
decrease |
Positive |
p < 0.05 |
172 |
Metformin |
0.5 mM |
24 hours |
human |
MCF7 |
Meassurement of coupled respiration |
decrease |
Positive |
p < 0.05 |
172 |
Metformin |
5 mM |
24 hours |
human |
MCF7 |
Meassurement of coupled respiration |
decrease |
Positive |
p < 0.05 |
172 |
Metformin |
0.5 mM |
24 hours |
mouse |
NMuMG |
Meassurement of mitochondrial respiration |
decrease |
Positive |
p < 0.05 |
172 |
Metformin |
0.5 mM |
24 hours |
mouse |
NT2196 |
Meassurement of mitochondrial respiration |
decrease |
Positive |
p < 0.05 |
172 |
Metformin |
0.5 mM |
24 hours |
human |
MCF10A |
Meassurement of mitochondrial respiration |
decrease |
Positive |
p < 0.05 |
172 |
Metformin |
0.5 mM |
24 hours |
human |
MCF7 |
Meassurement of mitochondrial respiration |
decrease |
Positive |
p < 0.05 |
172 |
Metformin |
66 mM |
|
Bovine |
heart mitochondria |
Measurement of complex I activity |
decrease |
Positive |
IC50 |
15 |
buformin |
11.3 mM |
|
Bovine |
heart mitochondria |
Measurement of complex I activity |
decrease |
Positive |
IC50 |
15 |
Phenformin |
1.2 mM |
|
Bovine |
heart mitochondria |
Measurement of complex I activity |
decrease |
Positive |
IC50 |
15 |